Literature DB >> 11417753

Impaired renal autoregulation: implications for the genesis of hypertension and hypertension-induced renal injury.

B F Palmer1.   

Abstract

In summary, autoregulation of the renal vasculature provides a mechanism by which renal function is maintained relatively constant despite variations in systemic blood pressure. This system also provides a means for changes in blood pressure to occur without causing inappropriate alterations in urinary NaCl excretion. Alterations in the autoregulatory response can have clinical consequences. Increased activity of the TGF mechanism may be causally related to the development of some forms of hypertension. Decreased activity of TGF or an impaired myogenic response may help explain the increased susceptibility that certain patient groups exhibit toward hypertension-induced renal injury. The aggressive treatment of hypertension in patients with impaired renal autoregulation may be associated with an increase in the serum creatinine concentration. As long as this increase is neither excessive nor progressive, physicians should not be dissuaded from trying to achieve newly established blood pressure goals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11417753     DOI: 10.1097/00000441-200106000-00005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  14 in total

Review 1.  Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.

Authors:  Clyde W Yancy
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

2.  Age and Outcomes Associated with BP in Patients with Incident CKD.

Authors:  Csaba P Kovesdy; Ahmed Alrifai; Elvira O Gosmanova; Jun Ling Lu; Robert B Canada; Barry M Wall; Adriana M Hung; Miklos Z Molnar; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-21       Impact factor: 8.237

Review 3.  Management of the cardiorenal syndrome in decompensated heart failure.

Authors:  Frederik Hendrik Verbrugge; Lars Grieten; Wilfried Mullens
Journal:  Cardiorenal Med       Date:  2014-12       Impact factor: 2.041

4.  Optimizing blood pressure control in patients with chronic kidney disease.

Authors:  Biff F Palmer; Andrew Z Fenves
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-07

Review 5.  Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management.

Authors:  Peter N Van Buren; Robert Toto
Journal:  Adv Chronic Kidney Dis       Date:  2011-01       Impact factor: 3.620

Review 6.  Environmental origins of hypertension: phylogeny, ontogeny and epigenetics.

Authors:  Melvin Khee-Shing Leow
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

7.  Renal inflammation and elevated blood pressure in a mouse model of reduced {beta}-ENaC.

Authors:  Heather A Drummond; Samira C Grifoni; Ahmed Abu-Zaid; Monette Gousset; Rumbidayzi Chiposi; John M Barnard; Beau Murphey; David E Stec
Journal:  Am J Physiol Renal Physiol       Date:  2011-05-04

Review 8.  Hypertension management in patients with chronic kidney disease.

Authors:  Biff F Palmer
Journal:  Curr Hypertens Rep       Date:  2008-10       Impact factor: 5.369

9.  Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.

Authors:  Jan Michael Williams; Mukut Sharma; Siddam Anjaiahh; John R Falck; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2007-05-16

10.  Effect of epithelial sodium channel blockade on the myogenic response of rat juxtamedullary afferent arterioles.

Authors:  Zhengrong Guan; Jennifer S Pollock; Anthony K Cook; Janet L Hobbs; Edward W Inscho
Journal:  Hypertension       Date:  2009-08-31       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.